rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6D
|
pubmed:dateCreated |
2001-4-30
|
pubmed:abstractText |
Carcinoembrionic Antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9) are the most commonly used tumor-associated antigens in the management of patients with colorectal cancer. The aim of this study was to evaluate the prognostic value of preoperative serum levels of CEA and/or CA 19-9 and the classical prognostic factors (age, sex, tumor infiltration and staging) in 495 patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0250-7005
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5195-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11326694-CA-19-9 Antigen,
pubmed-meshheading:11326694-Carcinoembryonic Antigen,
pubmed-meshheading:11326694-Colorectal Neoplasms,
pubmed-meshheading:11326694-Female,
pubmed-meshheading:11326694-Humans,
pubmed-meshheading:11326694-Male,
pubmed-meshheading:11326694-Multivariate Analysis,
pubmed-meshheading:11326694-Prognosis,
pubmed-meshheading:11326694-Retrospective Studies,
pubmed-meshheading:11326694-Survival Analysis,
pubmed-meshheading:11326694-Tumor Markers, Biological
|
pubmed:articleTitle |
Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
|
pubmed:affiliation |
Institute of Clinical Chemistry, Klinikum of the University Munich, Grosshadern, Germany. wolfgang.reiter@klch.med.uni-muenchen.de
|
pubmed:publicationType |
Journal Article
|